Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia

Clinical trial NCT00330382 · COMPLETED

Trial details

NCT number: NCT00330382
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lip and Oral Cavity Cancer Oral Leukoplakia Oropharyngeal Cancer Tongue Cancer

Start date: 1999-01-01
Primary completion: 2010-07-01
Enrollment: 325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.